These results indicate that ER-α36 mediates pterostilbene to inhibit MAPK/ERK and PI3K/Akt phosphorylation in breast cancer cells, and ER-α36 knockdown totally deactivates ERK1/2 and Akt phosphorylation in Mb231/Si36 cells. This evidence concerns the gene AKT1 and breast carcinoma.